Martha Grogan

机构：Mayo Clinic, WinnMed, Mayo Clinic in Arizona · ORCID：0000-0002-2541-4440

发表论文 346 篇 · 总被引 22958 次 · h-index 66

代表论文

• Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy (2025 · Journal of the American College of Cardiology · 被引 52)
• Value of Artificial Intelligence for Enhancing Suspicion of Cardiac Amyloidosis Using Electrocardiography and Echocardiography: A Narrative Review (2025 · Journal of the American Heart Association · 被引 20)
• Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial (2025 · Circulation · 被引 15)
• Echocardiographic Phenotypic Differences Between Light-Chain and Transthyretin Cardiac Amyloid and Relation to Outcome (2025 · Journal of the American Society of Echocardiography · 被引 6)
• Phenotypic Presentation and Longitudinal Characterization of Hereditary ATTRv Amyloidosis in Previously Undiagnosed Family Members (2025 · JACC Advances · 被引 5)
• Comparative performance of 99mTc-pyrophosphate vs. 99mTc-hydroxymethylene diphosphonate for cardiac amyloid radionuclide imaging (2025 · Journal of Nuclear Cardiology · 被引 4)